Chondroitin sulfate and heparan sulfate-containing proteoglycans are both partners and targets of basic fibroblast growth factor-mediated proliferation in human metastatic melanoma cell lines

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 1, 2008, Pages 72-83

  Nikitovic, D ^a   Assouti, M ^a   Sifaki, M ^b   Katonis, P ^a   Krasagakis, K ^b   Karamanos, N K ^c   Tzanakakis, G N ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Chondroitin sulfate; FGF 2; Heparan sulfate; Human melanoma cell lines

Indexed keywords

CHONDROITIN SULFATE; DERMATAN SULFATE; FIBROBLAST GROWTH FACTOR; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; NEUTRALIZING ANTIBODY; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; SODIUM CHLORATE;

ARTICLE; CANCER GROWTH; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA CELL; MITOGENESIS; SULFATION;

AUTOCRINE COMMUNICATION; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHONDROITIN SULFATES; FIBROBLAST GROWTH FACTORS; GLYCOSAMINOGLYCANS; HEPARITIN SULFATE; HUMANS; MELANOMA; NEOPLASM METASTASIS; PROTEIN-TYROSINE KINASES; PROTEOGLYCANS;

EID: 35748954602     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2007.06.019     Document Type: Article

References (39)

1. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. Journal of Biological Chemistry 262 (1987) 5592-5595
2. Ashikari-Hada S., Habuchi H., Kariya Y., Itoh N., Redii A.H., and Kimata K. Characterization of growth factor-binding structures in heparin/heparin sulphate using an octasaccharide library. Journal of Biological Chemistry 279 (2004) 12346-12354
3. Aviezer D., Iozzo R.V., Noonan D.M., and Yayon A. Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA. Molecular Cell Biology 17 (1997) 1938-1946
4. Bao X., Nishimura S., Mikami T., Yamada S., Itoh N., and Sugakahara K. Chondroitin sulfate/dermatan sulfate hybrid chains from embryonic pig brain, which contain a higher proportion of l-iduronic acid than those from adult pig brain, exhibit neuritogenic and growth factor binding activities. Journal of Biological Chemistry 279 (2004) 9765-9776
5. Basilico C., and Moscatelli D. Advances in Cancer Research 56 (1992) 115-165
6. Beckcer D., Meier C.B., and Herlyn M. Proliferation of human malignant melanoma is inhibited by antisesnse oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO Journal 8 (1989) 3685-3691
7. Delehedde M., Deudon E., Boilly B., and Hondermarck H. Heparan sulphate proteoglycans play a dual role in regulating fibroblast growth factor mitogenic activity in human breast cancer cells. Experimental Cell Research 229 (1996) 398-406
8. Deepa S.S., Yamada S., Zako M., Goldberger O., and Sugahara K. Chondroitin sulphate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparin sulphate chains to bind growth factors. A novel function to control binding of midkine, pleiotrophin, and basic fibroblast growth factor. Journal of Biological Chemistry 279 (2004) 37368-37376
9. Eswarakumar V.P., Lax I., and Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Review 16 (2005) 139-149
10. Fannon M., and Nugent M.A. Basic fibroblast growth factor binds its receptors, is internalized, and stimulates DNA synthesis in Balb/c3T3 cells in the absence of heparin sulfate. Journal of Biological Chemistry 271 (1996) 17949-17956
11. Herlyn M., Balaban M., Bennicelli J., Guerry D., Halaban R., Herlyn D., et al. Primary melanoma cells of the vertical growth phase: Similarities to metastatic cells. Journal of National Cancer Institute 74 (1985) 283-289
12. Jaye M., Schlessinger J., and Dionne C.A. Fibroblast growth factor receptor tyrosine kinases: Molecular analysis and signal transduction. Biochimca et Biophysica Acta 1135 (1992) 185-199
13. Karamanos N.K. Proteoglycans: Biological roles and strategies for isolation and T determination of their glycan constituents. In: Kamp R.M., Kyriakidis D.A., and Choli-Papadopoulou T. (Eds). Proteome and protein analysis (1998), Springer-Verlag, Berlin 342-363
14. Karamanos N.K., Axelsson S., Vanky P., Tzanakakis G.N., and Hjerpe A. Determination of hyaluronan and galactosaminoglycan disaccharides by high-performance capillary electrophoresis at the attomole level. Applications to analyses of tissue and cell culture proteoglycans. Journal of Chromatography A 696 (1995) 295-305
15. Karamanos N.K., Vanky P., Tzanakakis G.N., Tsegenidis T., and Hjerpe A. Ion-pair high-performance liquid chromatography for determining disaccharide composition in heparin and heparan sulphate. Journal of Chromatography A 765 (1997) 169-179
16. Liao S.K., Dent P.B., and McCulloch P.B. Characterization of human malignant melanoma cell lines. Journal of National Cancer Institute 54 (1975) 1037-1044
17. Ling L., Murali S., Dombrowski C., Haupt L.M., Stein G.S., van Wijnen A.J., et al. Sulfated glycosaminoglycans mediate the effects of FGF2 on the osteogenic potential of rat calvarial osteoprogenitor cells. Journal of Cellular Physiology 209 (2006) 811-825
18. Meier F., Newsbyte M., Hsu M.Y., Martin B., Van Belle P., Elder D.E., et al. Human melanoma progression in skin reconstructs: Biological significance of bFGF. American Journal of Pathology 156 (2000) 193-200
19. Mendes de Aguiar C.B., Garcez R.C., Alvarez-Silva M., and Trentin A.G. Undersulfation of proteoglycans and proteins alter C6 glioma cells proliferation, adhesion and extracellular matrix organization. International Journal of Developmental Neurosciences 20 (2002) 563-571
20. Mohammadi M., Olsen S.K., and Ibrahimi O.A. Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Reviews 16 (2005) 107-137
21. Molteni M., Modrowski D., Hott M., and Marie P.J. Alterations of matrix- and cell-associated proteoglycans inhibit osteogenesis and growth response to fibroblast growth factor-2 in cultured rat mandibular condyle and calvaria. Cell Tissue Research 295 (1999) 523-536
22. Nikitovic D., Zafiropoulos A., Tzanakakis G.G., Karamanos N.K., and Tsatsakis A.M. Effects of glycosaminoglycans on cell proliferation of normal osteoblasts and human osteosarcoma cells depend on their type and fine chemical composition. Anticancer Research 25 (2005) 2851-2856
23. Rahmoune H., Chen H.L., Gallagher J.T., Rudland P.S., and Fernig D.G. Interaction of heparan sulfate from mammary cells with acidic fibroblast growth factor (FGF) and basic FGF. Regulation of the activity of basic FGF by high and low affinity binding sites in heparan sulfate. Journal of Biological Chemistry 273 (1998) 7303-7310
24. Rapraeger A.C., Krugka A., and Olwin B.B. Requirement of heparin sulphate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252 (1991) 1705-1708
25. Reiland J., Kempf D., Roy M., Denkins Y., and Marchetti D. FGF2 binding, signalling, and angiogenesis are modulated by heparanase in metastatic melanoma cells. Neoplasia 8 (2006) 596-606
26. Rizzino A., Kuszynski C., Ruff E., and Tiesman J. Production and utilization of growth factors related to fibroblast growth factor by embryonal carcinoma cells and their differentiated cells. Developmental Biology 129 (1988) 61-71
27. Rodeck U. Growth factor independence and growth regulatory pathways in human melanoma development. Cancer Metastasis Review 12 (1993) 219-226
28. Rodeck U., Melber K., Kath R., Menssen H.D., Varello M., Atkinson B., et al. Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. Journal of Investigative Dermatology 97 (1991) 20-26
29. Rofstad E.K., and Halsor E.F. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Cancer Research 60 (2000) 4932-4938
30. Shih I.M., and Herlyn M. Role of growth factors and their receptors in the development and progression of melanoma. Journal of Investigative Dermatology 100 (1993) 196S-203S
31. Smith S.M.L., West L.A., Govindraj P., Zhang X.D., Ornitz M., and Hassel J.R. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors. Matrix Biology 3 (2007) 175-184
32. Su G., Meyer K., Nandini C.D., Qiao D., Salamat S., and Friedl A. Glypican-1 is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cells. American Journal of Pathology 168 (2006) 2014-2026
33. Taylor K.R., Rudisill J.A., and Gallo R. Structural and sequence motifs in dermatan sulfate for promoting fibroblast growth factor-2 (FGF-2) and FGF-7 activity. Journal of Biological Chemistry 280 (2005) 5300-5306
34. Timar J., Diczhazi C., Bartha I., Pogany G., Paku S., Tovari J., et al. Modulation of heparin-sulphate/chondroitin-sulphate ratio by glycosaminoglycan biosynthesis inhibitors affects liver metastatic potential of tumor cells. International Journal of Cancer 62 (1995) 755-761
35. Tzanakakis G.N., Hjerpe A., and Karamanos N.K. Proteoglycan synthesis induced by transforming and basic fibroblast growth factors in human malignant mesothelioma is mediated through specific receptors and the tyrosine kinase intracellular pathway. Biochimie 79 (1997) 323-332
36. Tzanakakis G.N., Karamanos N.K., and Hjerpe A. Effects on glycosaminoglycan synthesis in cultured human mesothelioma cells of transforming, epidermal, and fibroblast growth factors and their combinations with platelet-derived growth factor. Experimental Cell Research 220 (1995) 130-137
37. Wang Y., and Becker D. Antisense targeting of basis fibroblast growth factor and fibroblast growth factor receptor-1 in human melanoma blocks intratumoral angiogenesis and tumor growth. Nature Medicine 8 (1997) 887-893
38. Yayon A., Klagsbrun M., Esko J.D., Leder P., and Ornitz D.M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64 (1991) 841-848
39. Yeoman L.C. An autocrine model for cell- and matrix-associated fibroblast growth factor. Oncology Research 5 (1993) 489-499